53BP1 Regulates DSB Repair Using Rif1 to Control 5′ End Resection
The choice between double-strand break (DSB) repair by either homology-directed repair (HDR) or nonhomologous end joining (NHEJ) is tightly regulated. Defects in this regulation can induce genome instability and cancer. 53BP1 is critical for the control of DSB repair, promoting NHEJ, and inhibiting the 5′ end resection needed for HDR. Using dysfunctional telomeres and genome-wide DSBs, we identify Rif1 as the main factor used by 53BP1 to impair 5′ end resection. Rif1 inhibits resection involving CtIP, BLM, and Exo1; limits accumulation of BRCA1/BARD1 complexes at sites of DNA damage; and defines one of the mechanisms by which 53BP1 causes chromosomal abnormalities in Brca1-deficient cells. These data establish Rif1 as an important contributor to the control of DSB repair by 53BP1.
T he DNA damage response protein 53BP1 can influence the type of DNA repair at double-strand breaks (DSBs) (1) as seen in immunoglobulin gene rearrangements (2) (3) (4) and in the fusion of telomeres rendered dysfunctional through the removal of the shelterin protein TRF2 (5) , where 53BP1 enhances the mobility of damaged telomeres, thus potentially promoting the chance of telomere-telomere encounters. In Brca1-deficient cells, 53BP1 enhances aberrant nonhomologous end joining (NHEJ) events that create lethal radial chromosomes in response to poly(ADP-ribose) polymerase PARP1 inhibitors (PARPi) (6) . In this setting, 53BP1 may favor NHEJmediated misrejoining by blocking the DSB resection needed for homology-directed repair (HDR) (6, 7) . 53BP1 was shown to impede 5′ end resection at dysfunctional telomeres lacking all shelterin proteins and, similarly, telomeres lacking only TRF2 show evidence of 53BP1-dependent protection from resection (5, 8) . Based on the finding that an allele of 53BP1 (53BP1
28A
) lacking all potential ataxia telangiectasia mutated (ATM)/ATM and Rad3-related (ATR) kinase S/TQ target sites did not support immunoglobulin class switch recombination (CSR) and failed to generate radial chromosomes in Brca1-deficient cells (7) , it appears that these functions of 53BP1 involve interacting partner(s) modulated by the S/TQ sites. One candidate 53BP1-interacting factor is Rif1, which localizes to DSBs and dysfunctional telomeres, in a manner that is dependent on ATM signaling (9) (10) (11) . Rif1 was originally identified as part of the telomeric complex in budding yeast (12) and was recently shown to inhibit resection at yeast telomeres (13, 14) . In contrast, mammalian Rif1 has no known function at functional telomeres but contributes to the intra-S phase checkpoint, facilitates recovery from replication stress, and affects replication timing (10, (15) (16) (17) .
We introduced 53BP1 28A and other 53BP1 mutant alleles (7) into immortalized TRF2 F/-53BP1 −/− mouse embryo fibroblasts (MEFs) and induced telomere dysfunction by deletion of TRF2 (Fig. 1,  A and B) . The results showed that the S/TQ sites were required for the accumulation of Rif1 at deprotected telomeres, whereas the GAR, BRCT, and oligomerization domains of 53BP1 were not (Fig. 1, A to C, and fig. S1 ). The functional importance of the Rif1-53BP1 interaction was addressed using a telomere-based assay system that previously uncovered the role of 53BP1 in stimulating telomeric NHEJ and protecting telomere ends from 5′ resection (5, 8) . Using TRF2/Rif1 conditional double-knockout MEFs, we documented a significant reduction in the incidence and rate of telomere fusions in cells lacking Rif1 (Fig. 2, A to C, and fig. S2A ). This reduced NHEJ rate was not due to changes in cell cycle progression or diminished activation of the ATM kinase pathway by the deprotected telomeres ( fig. S2 , B to G).
As 53BP1 increases the mobility of dysfunctional telomeres, we determined whether Rif1 contributes to this aspect of 53BP1 by live-cell imaging of mCherry fused to the 53BP1 Tudor domain, which targets this marker to dysfunctional telomeres ( fig. S2H ). As expected, traces of the mCherry marker demonstrated that 53BP1 deficiency reduced the mobility of dysfunctional telomeres (Fig. 2D) . In contrast, absence of Rif1 did not affect the mobility of the deprotected telomeres. Thus, Rif1 is not required for the 53BP1-dependent increase in the mobility of dysfunctional telomeres.
We next determined whether Rif1 contributes to the inhibition of 5′ end resection by 53BP1. When TRF2 is deleted from cells lacking 53BP1, there is a 2-to 3-fold increase in the telomeric 3′ overhang signal (5) which can be detected based on annealing a telomeric oligonucleotide to native telomeric DNA (Fig. 3) . As expected, deletion of TRF2 resulted in the removal of the overhangs concomitant telomere fusion, whereas the overhang signal increased 3-fold when TRF2 was deleted from 53BP1-deficient cells in which telomeric NHEJ is rare and 5′ end resection is uninhibited (Fig. 3, A and B) . Deletion of TRF2 from Rif1-deficient cells also resulted in an increase in the overhang signal (Fig. 3B) . However, the increase was less compared to that observed in the 53BP1-deficient cells. Because the difference might be due to the lower rate of telomere fusions in the 53BP1-deficient setting, we generated immortalized TRF2
Rif1
F/F cells, which, owing to the absence of DNA ligase IV, have the same low telomere fusions rates as TRF2
−/− cells (5). When NHEJ was blocked, the telomeric overhang increase in the Rif1-deficient cells was the same as that which occurred in the 53BP1-deficient cells (Fig. 3, C and D) . The increase in overhang signal was demonstrably due to 3′ terminal sequences because the signal was removed by digestion with the Escherichia coli 3′ exonuclease ExoI ( fig. S3A ). These data suggest that Rif1 is the main factor acting downstream of 53BP1 to inhibit the resection at telomeres that lack TRF2 protection.
At telomeres that are deprived of both TRF1 and TRF2 and therefore lack all shelterin proteins, 53BP1 blocks extensive 5′ end resection that involves CtIP, BLM, and Exo1 (8) . To test the ability of Rif1 to inhibit resection at such shelterin-free telomeres, we generated immortalized TRF1 F/F TRF2 F/F Rif1 F/F MEFs. As expected, deletion of TRF1 and TRF2 resulted in frequent telomere fusions and nearly complete loss of the telomeric overhang signal when Rif1 was present (Fig. 3 , E and F). When Rif1 was codeleted with TRF1 and TRF2, telomere fusions were also frequent, resulting in most telomeric restriction fragments shifting to a higher molecular weight (Fig. 3E) . However, the telomeres that had not fused at the time point analyzed showed a notable increase in overhang signal (Fig. 3, E and F) . This increase in the signal was diminished when cells were treated with short hairpin RNAs (shRNAs) against CtIP, BLM, or Exo1 (Fig. 3 , G and H, and fig. S3 , B and C). Thus, like 53BP1, Rif1 inhibits 5′ end resection that involves CtIP, BLM, and Exo1. We next asked whether Rif1 affects resection at zeocin-induced DSBs by monitoring the formation of replication protein A (RPA) foci (Fig.  4A and fig. S4A ). The absence of either Rif1, 53BP1, or both did not affect zeocin-induced g-H2AX foci or the basal level of cells containing g-H2AX foci, which likely represent replicating cells (Fig. 4, A and B) . However, in zeocintreated cells, the absence of either Rif1 or 53BP1 resulted in a significant increase in g-H2AX foci that colocalized with RPA (Fig. 4 , A and C). When either 53BP1 or Rif1 were absent, there also was a significant increase in g-H2AX foci containing RPA in cells not treated with zeocin, presumably reflecting a higher level of resection at stalled replication forks (Fig. 4, A and C) . Examination of the RPA/g-H2AX foci in zeocin-treated Rif1/53BP1 double-knockout cells indicated that Rif1 and 53BP1 are epistatic in this regard because the induction of RPA/g-H2AX foci in absence of 53BP1 was the same as in Rif1-deficient cells and the absence of both Rif1 and 53BP1 did not further increase the response (Fig. 4C) . The simplest interpretation of these data is that Rif1 is the main factor acting downstream of 53BP1 to block 5′ end resection at the zeocininduced DSBs.
Because the 53BP1/Rif1 control affects CtIP, which is thought to be delivered by a complex containing BRCA1 (18) (19) (20) , we also determined whether 53BP1 and Rif1 had an effect on the presence of the BRCA1 at zeocin-induced DSBs. Using an antibody to the constitutive BRCA1 partner BARD1, we found that absence of Rif1 or 53BP1 resulted in a significant increase in the accumulation of BRCA1 complexes at zeocin-induced DSBs (Fig. 4 , E and F). Consistent with the data above, Rif1 and 53BP1 were again epistatic in this regard. The absence of 53BP1 resulted in the same phenotype as absence of Rif1, and the double knockout did not show an additional increase in the incidence of BARD1 foci (Fig. 4 , E and F). The absence of Rif1 also resulted in an increase in the presence of BARD1 at dysfunctional telomeres ( fig. S4 , B to D).
Because 53BP1 mediates the formation of misrejoined and radial chromosomes in PARPitreated Brca1-deficient cells, we asked to what extent Rif1 is responsible for this effect. Cells lacking Rif1, 53BP1, or both were treated with a BRCA1 shRNA and the PARP inhibitor, and misrejoined chromosomes were quantified (Fig. 4 , G and H). The data show the previously documented decrease in the frequency of chromosome misrejoining when 53BP1 is absent. Interestingly, absence of Rif1 also lowers the frequency of chromosome misrejoining, but the effect is significantly less than for 53BP1. Thus, the formation of misrejoined chromosomes in PARPi-treated Brca1-deficient cells is due to two distinct attributes of 53BP1, one of which requires Rif1 function.
These data identify Rif1 as the major factor acting downstream of 53BP1 in the control of 5′ end resection. In contrast, Rif1 does not appear to be required for the ability of 53BP1 to promote an increase in the mobility of dysfunctional telomeres. The intermediate effect of Rif1 on the fusion of dysfunctional telomeres can be explained based on these two observations. The increased resection of dysfunctional telomeres in absence of Rif1 is likely to be responsible for the mild inhibition of NHEJ. However, in the absence of 53BP1, the effect of increased resection is combined with a defect in the induction of the mobility of the dysfunctional telomeres, resulting in a more severe blockade to NHEJ. Similarly, we propose that Rif1 deletion leads to partial rescue of chromosome misrejoining in PARPi/BRCA1 shRNA-treated cells because the control of 5′ end resection is only one of multiple mechanisms by which 53BP1 acts. One possibility is that the other mechanism used by 53BP1 in this context, similar to what happens at dysfunctional telomeres, involves the induction of DSB mobility that increases the chance that DSB misrejoining occurs. husbandry The timing of the induction of flowering determines to a large extent the reproductive success of plants. Plants integrate diverse environmental and endogenous signals to ensure the timely transition from vegetative growth to flowering. Carbohydrates are thought to play a crucial role in the regulation of flowering, and trehalose-6-phosphate (T6P) has been suggested to function as a proxy for carbohydrate status in plants. The loss of TREHALOSE-6-PHOSPHATE SYNTHASE 1 (TPS1) causes Arabidopsis thaliana to flower extremely late, even under otherwise inductive environmental conditions. This suggests that TPS1 is required for the timely initiation of flowering. We show that the T6P pathway affects flowering both in the leaves and at the shoot meristem, and integrate TPS1 into the existing genetic framework of flowering-time control.
T he transition from vegetative to reproductive development is an important phase change in a plant's life. When timed correctly, the transition helps to ensure reproductive success and therefore has adaptive value. For this reason, plants have evolved an intricate genetic network that controls the onset of flowering in response to environmental and endogenous signals such as day length, temperature, hormonal status, and carbohydrate availability (1). Day length is perceived in the leaves, where a sufficiently long day (i.e., an inductive photoperiod) leads to induction of the FLOWERING LOCUS T (FT ) gene (2-7). The FT protein functions as a long-distance signal (florigen) that is transported to the shoot meristem, where it interacts with the bZIP transcription factor FD and triggers the formation of flowers (8) (9) (10) (11) .
In contrast to the detailed understanding of the photoperiod pathway, relatively little is known about the contribution of carbohydrates to the regulation of flowering (12) . Mutations in genes of key enzymes in sugar and starch metabolism such as HEXOKINASE1 (HXK1) and PHOSPHO-GLUCOMUTASE1 (PGM1) have been shown to affect various aspects of development, including flowering (13) . A particularly striking example in this respect is TREHALOSE-6-PHOSPHATE SYNTHASE 1 (TPS1), which catalyzes the formation of trehalose-6-phosphate (T6P) from glucose-6-phosphate and uridine diphosphate (UDP)-glucose (13, 14) . T6P, which is found only in trace amounts in most plants, has been suggested to function as a signaling molecule that relays information about carbohydrate availability to other signaling pathways (15) . In agreement with the proposed role of T6P as a central hub in carbon signaling, TPS1 loss-of-function mutants are embryonic lethal (16) . Expression of TPS1 from the seed-specific ABI3 promoter has been shown to be sufficient to rescue the embryo defect, but the resulting homozygous tps1 ABI3:TPS1 plants develop slowly and senesce before entering the reproductive phase (17) . Homozygous tps1-2 mutants have also been recovered using a chemically inducible rescue construct (GVG:TPS1), which enables induction of TPS1 by dexamethasone application, allowing the tps1-2 GVG:TPS1 embryos to be rescued to give viable plants that can be stably maintained (18) . The resulting tps1-2 GVG:TPS1 plants flower extremely late, producing infertile flowers on shoots that simultaneously arise from the shoot apical meristem (SAM) and axillary meristems, or completely fail to flower, even under inductive photoperiod. These findings indicate that TPS1 plays a critical role in controlling the transition to flowering. However, it is currently unclear where TPS1 is integrated into the canonical flowering-time pathways.
To better understand the molecular function of TPS1, we first confirmed its effect on flowering by knocking down TPS1 expression with the use of an artificial microRNA (35S:amiR-TPS1; figs. S1 and S2) (19) . This resulted in a significant 25 to 30% reduction in T6P levels ( fig. S3 ) and a delay in flowering by more than 20 leaves (Table 1, experiment 1; fig. S4 ). In contrast, sucrose levels were significantly higher in 35S:amiR-TPS1 plants ( fig. S4 ), indicating that carbohydrate availability as such was not compromised in those plants. These findings highlight 
MATERIALS and METHODS

Cell culture and generation of genetically modified MEFs
Rif1
F/F , TRF2 F/F , TRF1 F/F , 53BP1 -/-, and Lig4 -/-mice were described previously (1-5).
Compound genotypes were obtained by intercrossing and MEFs were isolated from E13.5 or E12.5 (for Lig4 -/-) embryos using standard techniques. Genotyping was performed by Transnetyx using real-time PCR. Primary MEFs were immortalized at PD 1 or 2 by two consecutive retroviral infections with pBabe-SV40LT (a gift from G. Hannon) and cultured in DMEM (GIBCO) supplemented with 10 or 15% fetal bovine serum (GIBCO), 2 mM L-glutamine, 100 U/ml penicillin (Sigma), 0.1 mg/ml streptomycin (Sigma), 0.1 mM nonessential amino acids (Invitrogen), 1 mM sodium pyruvate (Sigma), and 50 mM β-mercaptoethanol (Chemicon). 293T and Phoenix virus packaging cell lines were grown in DMEM supplemented with 10% bovine calf serum (Hyclone), glutamine, nonessential amino acids and penicillin/streptomycin as above.
Cre-mediated gene deletion
The Cre recombinase was introduced by three consecutive infections with a pMMP Hit&Run Cre retrovirus without subsequent antibiotic selection. For expression of exogenous protein constructs, 2-3 infections in 12 h intervals were applied. 12 h after the last infection, 5x10 5 infected cells were plated in selective media containing appropriate antibiotics (1.5-2 µg/ml puromycin or 90 µg/ml hygromycin). Selection was maintained until all cells in an uninfected control plate were dead (2-3 days for puromycin and 5-7 days for hygromycin).
For transduction of shRNA encoding plasmids, 5-6 infections in 4 h intervals over two days were used. 12 h after the last infection, 5x10 5 cells were plated into selective media. Where desirable, Cre-mediated gene deletion was performed after shRNA infections as described above. The first pMMP Hit&Run Cre infection was applied 48 h after the last shRNA infection.
Immunoblotting
Immunoblotting was performed as described previously (4 
Live-cell imaging and chromatin mobility measurement
Live-cell imaging was performed essentially as described previously (10) . Dysfunctional telomeres were visualized using a previously characterized mCherry-53BP1 objective lens (Olympus). The system was operated using SoftWoRx software. 5-mm Zstacks at 0.5 mm steps were acquired every 30 s over 20 min (total 40 frames) at 2x binning and 512 x 512 pixel resolution. The movies were later deconvolved and maximum Z-projections were generated using SoftWorRx software.
Image analysis was conducted in ImageJ software. At first, the image stacks were registered using the StackReg plugin!(11), with the "scaled rotation" or "affine" settings) and trajectories of the individual TIFs were calculated by the ParticleTracker 3D plugin! (12) . The analysis parameters were set as follows: radius = 2 px; cutoff = 2 px; percentile = 2 -4; link range = 1; displacement = 5 px. Cumulative traveled distance was calculated for each trajectory as described previously (10) . At least ten cells were analyzed for each genotype per experiment. All dysfunctional telomeres continuously tracked for at least 35 frames were selected for analysis (on average ~30-40 trajectories per cell).
shRNAs shRNAs to BLM, CtIP, and Exo1 were previously described (6) . The targeting sequence of the BRCA1 shRNA was 5' GCAGCGTTCAGAAAGTTAA 3'.
IF and IF-FISH
IF and IF-FISH were performed as described previously (5, 7) . Cells were grown on coverslips to sub-confluence, washed with PBS and fixed in 3% paraformaldehyde/PBS for 10 min at room temperature. Fixed cells were permeabilized with Triton X-100 buffer (0.1% Triton X-100, 20 mM HEPES-KOH pH 7.9, 50 mM NaCl, 3 mM MgCl2, 300 mM For Myc-RPA and BARD1 staining, MEFs were infected with a Myc-tagged RPA32 retrovirus as described previously (8) and grown on poly-L-lysine coated coverslips (BD Biosciences). Soluble nucleoplasmic proteins were extracted prior to fixation using a published protocol (9) . Briefly, coverslips were washed twice with cold PBS, treated with cold cytoskeleton buffer (10 mM PIPES pH 6.8, 100 mM NaCl, 300 mM sucrose, 3 mM MgCl 2 , 1 mM EGTA, 0.5% Triton X-100) for 5 min and then 5 min with cold cytoskeleton stripping buffer (10 mM Tris-HCl pH 7.4, 10 mM NaCl, 3 mM MgCl 2 , 1% Tween 20, 0.5% Na + -deoxycholate). The cells were then washed 3x with cold PBS. All steps were performed on ice. Extracted cells on coverslips were then fixed with 3% paraformaldehyde, 2% sucrose in PBS (10 min, room temperature) and processed for IF as described above.
For BrdU staining, coverslips were treated with 4N HCl for 4 min at room temperature to denature DNA prior to incubation with antibodies.
Images were captured using a Zeiss Axioplan II microscope equipped with a Hamamatsu C4742-95 camera and controlled by OpenLab software (Improvision).
The following primary antibodies were used for immunoblotting and 
Telomere overhang analysis by in-gel hybridization
In gel assays to determine changes in the amount of single-stranded telomeric DNA were performed as described previously (4 
Induction of DSBs
DSBs were induced by adding 100 µg/ml zeocin (Invitrogen) to the media for 1 h. The drug was subsequently washed out and fresh media was added to the cells. The cells were incubated for an additional hour to allow DSB processing and then fixed and immunostained as described below. 
